Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Colonisation of Pathogens01:25

Colonisation of Pathogens

Pathogen colonization of host tissues is a critical step in the development of infectious diseases. Various pathogenic microorganisms, including bacteria, fungi, viruses, and protozoa, have evolved complex strategies to attach to, invade, and persist within host environments. These mechanisms enable pathogens to establish infections, evade immune responses, and resist antimicrobial treatments.Attachment to Host CellsIn bacteria, colonization typically begins with adherence to host epithelial...
Determinants of Bacterial Pathogenicity and Virulence01:20

Determinants of Bacterial Pathogenicity and Virulence

Pathogenic bacteria employ a variety of strategies to establish infections, including the secretion of extracellular enzymes that act as potent virulence factors. These enzymes facilitate bacterial colonization of host tissues and help evade immune surveillance. By targeting structural components of host tissues and interfering with immune mechanisms, these enzymes play a pivotal role in disease progression.Extracellular Enzymes Facilitating Tissue Invasion: Several bacterial pathogens secrete...
Human Virome01:26

Human Virome

The human body harbors a vast and diverse viral community known as the human virome. The virome includes bacteriophages that infect bacteria, and eukaryotic viruses that infect human cells. Transient dietary and environmental viruses also contribute to this dynamic ecosystem. Estimates suggest the human body may contain on the order of 10¹³ viral particles, though abundance varies widely by body site and detection method.Comprehensive characterization of the virome has become possible only with...
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Rapid Identification of Pathogens01:25

Rapid Identification of Pathogens

MALDI-TOF MS has transformed clinical microbiology by offering a rapid and reliable method for pathogen identification. The traditional approach to microbial identification typically involves time-consuming culture techniques and biochemical tests, which can delay the initiation of appropriate antimicrobial therapy. MALDI-TOF MS avoids these delays by using characteristic ribosomal protein mass patterns of microbial cells, enabling accurate species-level identification within minutes.Principle...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Aneuploidy selects for the acquisition of driver genes in breast cancer.

Nature·2026
Same author

Comparative Analysis of Transcription Factor Binding Sites in the Long Control Region Across Human Papillomavirus Types.

Viruses·2026
Same author

MORC3 represses a tandem repeat enhancer to regulate interferon.

The EMBO journal·2026
Same author

RepurNet: A network medicine framework for systematic drug repurposing and disease vulnerability discovery.

iScience·2026
Same author

Temporal control of sgRNA library activation unlocks large-scale in vivo CRISPR screens.

Cell reports methods·2026
Same author

Opsonization Improves Dual Proteomic Analysis of <i>Burkholderia cenocepacia</i> Infections.

Journal of proteome research·2026

Related Experiment Video

Updated: Jul 2, 2026

Identification of Host Pathways Targeted by Bacterial Effector Proteins using Yeast Toxicity and Suppressor Screens
07:40

Identification of Host Pathways Targeted by Bacterial Effector Proteins using Yeast Toxicity and Suppressor Screens

Published on: October 25, 2019

Systematic discovery of pathogen effector functions across human pathogens and pathways.

Tomas Pachano1, He Leng2, Guillaume Dugied2

  • 1Research Institute of Molecular Pathology (IMP), Vienna Biocenter (VBC), Vienna, Austria.

Cell
|June 30, 2026
PubMed
Summary

Scientists created a large collection of pathogen effector genes (eORFeome) to study how they manipulate host cells. This research identified new functions for many unknown effectors and revealed novel host-pathogen interaction mechanisms.

Keywords:
ORFeomeSTINGeffectorsfunctional genomicshigh-throughput screeninghost-pathogen interactionshuman signaling pathwaysp53pathogensviral proteins

More Related Videos

A Comparative Approach to Characterize the Landscape of Host-Pathogen Protein-Protein Interactions
13:56

A Comparative Approach to Characterize the Landscape of Host-Pathogen Protein-Protein Interactions

Published on: July 18, 2013

Label-Free Quantitative Proteomics Workflow for Discovery-Driven Host-Pathogen Interactions
05:37

Label-Free Quantitative Proteomics Workflow for Discovery-Driven Host-Pathogen Interactions

Published on: October 20, 2020

Related Experiment Videos

Last Updated: Jul 2, 2026

Identification of Host Pathways Targeted by Bacterial Effector Proteins using Yeast Toxicity and Suppressor Screens
07:40

Identification of Host Pathways Targeted by Bacterial Effector Proteins using Yeast Toxicity and Suppressor Screens

Published on: October 25, 2019

A Comparative Approach to Characterize the Landscape of Host-Pathogen Protein-Protein Interactions
13:56

A Comparative Approach to Characterize the Landscape of Host-Pathogen Protein-Protein Interactions

Published on: July 18, 2013

Label-Free Quantitative Proteomics Workflow for Discovery-Driven Host-Pathogen Interactions
05:37

Label-Free Quantitative Proteomics Workflow for Discovery-Driven Host-Pathogen Interactions

Published on: October 20, 2020

Area of Science:

  • Molecular Biology
  • Immunology
  • Virology
  • Microbiology

Background:

  • Pathogen effector proteins are crucial for host cell manipulation but often lack functional annotation.
  • Understanding these effectors is key to deciphering host-pathogen interactions and developing countermeasures.

Purpose of the Study:

  • To develop a scalable functional genomics platform (eORFeome) for annotating diverse pathogen effector open reading frames (ORFs).
  • To systematically investigate effector functions across critical human cellular pathways.

Main Methods:

  • Construction of the effector ORFeome (eORFeome) with 3,835 ORFs from various pathogens.
  • High-throughput barcoded screens of eORFeome across NF-κB, apoptosis, p53, cGAS-STING, and MHC class I pathways.

Main Results:

  • Hundreds of uncharacterized ORFs revealed novel pathway-modulating functions.
  • Known effectors displayed unexpected activities, and single ORFs showed distinct pathway-specific functions.
  • Identified specific effectors like HHV6A U14 (p53 antagonist) and HHV7 U21 (STING antagonist/MHC-I inhibitor).

Conclusions:

  • Established a framework for systematic effector annotation.
  • Uncovered new mechanisms of host-pathogen interaction across different pathogen types.
  • Highlighted pathogen effectors as tools for probing and manipulating human cellular pathways.